Simira Unipath Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-11-2024
- Paid Up Capital ₹ 0.15 M
as on 05-11-2024
- Company Age 5 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.42 M
as on 05-11-2024
- Satisfied Charges ₹ 1.72 Cr
as on 05-11-2024
- Revenue 82.89%
(FY 2023)
- Profit -245.15%
(FY 2023)
- Ebitda -53.06%
(FY 2023)
- Net Worth -140.93%
(FY 2023)
- Total Assets 88.14%
(FY 2023)
About Simira Unipath Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹9.42 M. The company has closed loans amounting to ₹1.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jwalant Shah, Santosh Wakchaure, and Aruna Wakchaure serve as directors at the Company.
- CIN/LLPIN
U85190MH2020PTC335458
- Company No.
335458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Simira Unipath Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jwalant Shah  | Director | 16-Jan-2024 | Current |
| Santosh Wakchaure | Director | 03-Jan-2020 | Current |
| Aruna Wakchaure | Director | 16-May-2023 | Current |
Financial Performance of Simira Unipath Diagnostics.
Simira Unipath Diagnostics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.89% increase. The company also saw a substantial fall in profitability, with a 245.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 140.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Simira Unipath Diagnostics?
In 2023, Simira Unipath Diagnostics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advanced Transfusion Medicine Research FoundationActive 27 years 8 monthsJwalant Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Jun 2023 | ₹5.00 M | Open |
Others Creation Date: 25 Apr 2023 | ₹2.62 M | Open |
Others Creation Date: 22 Jun 2022 | ₹1.80 M | Open |
How Many Employees Work at Simira Unipath Diagnostics?
Simira Unipath Diagnostics has a workforce of 129 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Simira Unipath Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Simira Unipath Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
